Fig. 3
From: The potential of chimeric antigen receptor -T cell therapy for endocrine cancer
Candidate target antigens for CAR-T cell therapy in endocrine cancer. Several target antigens for CAR-T cell therapy have been identified and are being studied in preclinical and clinical trials. Different tumor cells express both common and distinct antigens. For example, PC and OC tumor cells share target antigens for CAR-T therapy, including ERBB2, MSLN, MUC16, and CD24